MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$275,160,500
Product And Service
Other
$72,048,000
Urology
$29,005,500
Wound Care
$47,127,000
Ostomy
$53,209,500
Home Respiratory
Therapy Product
$108,262,500
Sleep Therapy Product
$185,013,000
Diabetes Product
$195,842,500
Loss from
discontinued operations, net...
-$249,490,000
(loss) income from
continuing operations, net...
-$25,670,500
Income tax benefit for
discontinued operations
-$9,726,750
Net revenue
$690,508,000
Loss from
discontinued operations...
-$259,216,750
Income tax provision
$182,250
(loss) income from
continuing operations...
-$25,488,250
Operating income (loss)
$6,865,000
Net revenue
$1,977,413,750
Total operating costs
and expenses
$683,643,000
Other expense
$351,250
Interest expense, net
-$9,000,250
Operating (loss) income
-$249,865,250
Other expense, net
-$985,500
Transaction financing fees,
net
$4,572,000
Interest expense, net
$26,795,750
Gross profit
$196,127,750
Cost of goods sold
$1,781,286,000
Exit and realignment
charges, net
$4,611,750
Acquisition-related charges and
intangible amortization
$23,958,000
Transaction breakage fee
$20,000,000
Selling, general and
administrative expenses
$266,890,000
Cost of net revenue
$368,183,250
Other operating
expense, net
-$2,733,000
Loss on
classification to held for sale
$199,733,500
Goodwill impairment
charge
$26,597,250
Exit and realignment
charges, net
$18,094,750
Acquisition-related charges and
intangible amortization
$3,137,250
Distribution, selling, and
administrative expenses
$195,697,250
Back
Back
Income Statement
source: myfinsight.com
ACCENDRA HEALTH INC VA (ACH)
ACCENDRA HEALTH INC VA (ACH)